Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Gene therapy scores against cancer

The first Phase II clinical trial to study the combination of a replicating viral agent with chemotherapy indicates that cancer gene therapy may finally be on the road to success. ( 879–885).

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Khuri, F.R. et al. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nature Med. 6, 879–885 (2000).

    Article  CAS  Google Scholar 

  2. Barker, D.D. & Berk, A.J. Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection. Virology 156, 107– 121 (1987).

    Article  CAS  Google Scholar 

  3. Yew, P.R & Berk, A.J. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature 357, 82–83 ( 1992).

    Article  CAS  Google Scholar 

  4. Heise, C. et al. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nature Med. 3, 639– 645 (1997).

    Article  CAS  Google Scholar 

  5. Rosenberg, S.A. et al. Gene transfer into humans – immunotherapy of patients with advanced melanoma, suing tumor-infiltrating lymphocytes modified by retroviral gene transduction. N. Engl. J. Med. 323, 570–578 (1990).

    Article  CAS  Google Scholar 

  6. Blaese, R.M. et al. T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science 270, 475–480 (1995).

    Article  CAS  Google Scholar 

  7. Kay, M.A. et al. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nature Genet. 24, 257–261 (2000).

    Article  CAS  Google Scholar 

  8. Isner, J.M. & Asahara, T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J. Clin. Invest. 103, 1231–1266 (1999).

    Article  CAS  Google Scholar 

  9. Cavazzana-Calvo, M. et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669– 672 (2000)

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anderson, W. Gene therapy scores against cancer. Nat Med 6, 862–863 (2000). https://doi.org/10.1038/78610

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/78610

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing